First Light
In 2028, every city street thrummed with 6G pulses and augmented-reality overlays. Delivery drones buzzed overhead, weaving through the urban skyline. Personal AIs whispered tailored suggestions into people’s ears, while biotech startups raced to perfect nanobot symbiotes—machines designed to heal humanity from the inside out. Tonight, the first human patients would discover just how deep that promise truly cut. 00:45 — The lab’s emergency lights flared to life, casting everything in a pulsing red haze. Dr. Helena Vos hesitated just outside the glass doors, attuned to the low hum of the refrigerated nanobot incubators and the faint, rhythmic click of the security shutters locking into place.
In these deep hours, two subjects in the clinical trial were about to cross a threshold—no longer just patients, but prototypes. And she wasn’t about to let a single variable slip through her fingers.
She swiped her keycard. The doors parted with a hiss.
Inside, the infusion wing was silent save for the steady hiss of cooling ducts. Five steel tanks lined the far wall, each marked with a project code and timestamp. Two stainless-steel tables stood beneath the central console, their surfaces gleaming beneath stark overhead lamps.
“Status report,” Vos called, her voice steady as she approached.
A young technician—James—scrubbed at his augmented-reality clipboard, the holographic interface flickering as his fingers danced over invisible controls.
“All systems are good to go, Dr. Vos… except Port A’s calibration. We’re showing a minus one-fifth-millimeter variance in liner depth.”
Vos's eyes narrowed. She tapped the console, zooming in on the port’s readout.
“We don’t start until it’s exact. Run the recalibration. I want that port reading zero point zero.”
“Understood,” James replied, already typing. The screen flickered as he issued the override.
Across the lab, two figures lay motionless on the infusion tables, shoulders exposed where the nanobot ports had been installed.
Vos stepped closer. Inspection lights traced the raised circles on each patient’s deltoid. Her lips curved into a small, clinical smile.
No room for error tonight. Phase One depended on every detail.
She turned back to the console.
“Let’s get this right. Initiate the primer cycle the moment the port’s reset.”
James hit enter. The room’s hum deepened—a low, resonant thrum that sounded like a heartbeat made of machines.
The Threshold Protocol had begun.
00:47 — Vos stepped away from the console as the primer cycle spun up, a soft tremor riding beneath the hum like a warning she refused to name. Red light pulsed across the glass, slicing through the lab in methodical waves. Everything looked clean. Controlled. Just the way it was supposed to.
Her fingers tightened around the edge of the console.
Nothing ever goes perfectly the first time, she thought. But we can’t afford another failure—not after Seville, not with funding reports due in eighteen days and eyes from three different agencies watching for a reason to shut us down.
She stared at the patients, their bodies still beneath the surgical drapes, deltoid ports shining with antiseptic sheen. The woman’s hand twitched—barely—but it was enough.
“James,” she said sharply. He flinched—subtle, but she caught it.
“Yes, Doctor?”
“Primer depth and sync calibration. Recheck them.”
“We already—” He paused mid-sentence, biting it back. “Yes, Doctor.”
Vos didn’t need to look; she knew his hands were already tapping twice on the holographic interface—his little tic, like knocking on wood. It made him slow, but reliable. And terrified.
She watched him through the glass as he verified the readings, his eyes darting between the tables and the scrolling data.
Too young for this level of clearance. Too careful for fieldwork. But he hadn’t quit after Munich. That counted for something.
Her gaze flicked to the male subject. A faint scar traced from his temple to jawline—old trauma, maybe a crash or impact injury. They never told her the full histories, just the metrics: bloodwork, response scores, neural elasticity.
That was all she needed.
But the girl… the twitch. Vos’s breath caught—not panic, but fascination.
My God, it’s starting already. This was five percent faster than the models predicted. The primer cycle was just beginning. The nanites shouldn’t even be live yet. Not fully.
She stepped forward, resting her gloved hand against the glass.
They were in the quiet before the thunder. And if this worked—really worked—it would rewrite everything. Not just healing. Not just enhancements. Something deeper.
Vos’s jaw tightened. Not just to prove them wrong. Though that part felt good. Not just to bury Seville under a mountain of results. She let her fingers curl.
This was the work that should’ve saved Eva. If it had come ten years earlier—if they’d had this tech then—her sister wouldn’t have bled out in that hillside wreck. A fractured liver. That was all. Something nanites could patch in seconds. Something no hospital could stop fast enough back then.
Helena had learned to speak in formulas and protocols because emotions didn’t solve bleeding. Science did. Design did. Precision saved lives.
Emotion just got in the way.
Behind her, James cleared his throat.
“Port readings stable, Doctor. Primer cycles holding within threshold. Neural latency is… low. Lower than baseline, actually.”
Vos blinked.
Interesting.
She stepped back from the glass, expression unreadable.
“Run a passive EEG overlay—full spectrum. Let’s see how deep the sync goes before Phase Two.”
“Yes, Doctor,” James murmured, tapping the command—once, then again, just to be sure.
The hum in the lab thickened, as if the walls themselves were holding their breath.
Vos turned to the display, eyes narrowing at the first tremors of activity lighting up across the cortical maps. No glitches. No drift.
Just something new awakening.
And deep in her chest, behind the wall of calculation and command, something stirred—half awe, half fear.
She silenced both.
“Begin biometric logging,” she said calmly. “The Threshold Protocol has officially entered Stage One.”
LAB – OBSERVATION ROOM
Red overlays pulsed across the neural display grids, the hum vibrating just below audible range. Helena stood with her hands clasped behind her back, eyes locked on the biometric readout for Subject A.
Female, early twenties. Athletic build. High neuromuscular recovery potential. Unusually stable synaptic profile. And something else—an edge in the EEG data that wasn’t quite a glitch.
She zoomed in.
“Still no voluntary movement,” James said, breaking the silence. His tone was clipped—his version of professional calm.
“Re-run the neural-interface diagnostics,” Helena said. “Activate the Delta-band sync overlay.”
James double-checked his HUD, then triple-checked—an unconscious tic. Vos noticed it but never called it out. Everyone had something. His was nerves. And awe.
Vos had seen it in how he lingered near the tanks after hours, reverent as if preparing astronauts for launch rather than test subjects for Phase II.
“Subject B’s baseline is flat,” James reported. “Still in regulated suspension. No anomalies.”
She turned to the second figure across from Subject A—male, broader frame. A small scar ran along his temple (not listed in his intake scan). Old trauma, probably. Residual tension curled in his fingers, even in stasis. She noted it.
Back to Subject A.
A faint twitch rolled through her right hand.
James noticed too. “Was that—?”
“Subthreshold reflex. Possibly spinal. Run it again,” Helena cut in.
She tapped the feed, isolating the tremor. There it was—rhythmic, controlled. Way too early.
Her ports hadn’t finished stabilizing.
Helena leaned forward, eyes narrowing. Silence stretched.
James hovered behind her, uncertain. “That’s the first sign since prep.”
“She’s not waking,” Helena said softly. “Her body’s responding to the mesh overlay. The nanites are… exploring.”
She did not voice what she suspected: this one was syncing. Already.
She exhaled through her nose—quiet, precise.
How long had the Phase I subjects taken to register even a thermal shift? This subject’s brain was adapting before primer cycle 2 had fully stabilized. It wasn’t the tech alone.
It was her.
A tightness gripped her chest. She filed it under biofeedback noise. Not emotion. Not attachment. Just… stress.
Vos stepped away from the glass, collecting herself.
“You know,” James offered hesitantly, “people would kill to be in that room right now.”
She glanced at him, unreadable.
“I’m already here.”
He winced. “Right. Sorry.”
“Reset the drift-variance monitor. I want a continuous stream.”
She paused at the door.
“And triple-check the log buffer. We’re not missing a single frame of this.”
Behind the glass, Subject A lay still—but her breathing was just a little deeper than the others. And her fingers? They twitched again. Once. Then stillness.
02:30 – LAB – PRIVATE OFFICE
A single holo-screen glowed against the glass wall. On its left, the sponsor’s secure feed blinked “Phase II Protocol: Immediate Initiation Required.” On the right, Helena’s private anomaly log scrolled silent red alerts—Subject A spikes, unexplained sync tremors, neural latency curves off the charts.
Helena closed her eyes. The distant hum of the Infusion Wing reminded her: there was no turning back.
Just one more test, she thought. Then we prove them wrong.
Her gloved fingers hovered over the comm panel. A message hovered beneath her cursor: “Proceed with Stage II.”
She tapped it. The screen flared green.
There’s no guarantee this won’t go sideways. But she already knew that. She remembered Seville’s debrief—how the board had laughed off her cautions. And Eva… if only Eva had had a chance.
A soft chime snapped her back.
JAMES (holo):
“Doctor—just to confirm, you want me to flag all sync anomalies under Threshold II and scrub the public logs?”
Helena inhaled. Every detail counts.
VOS:
“Yes. Flag and encrypt. Keep the public channel clean. And prep the Phase II dossiers—full clinical profiles, nothing held back.”
JAMES:
“Understood. Uploading now.”
He vanished. The office was empty again—save for her and the silent holo-screens.
She stood, staring at her reflection in the glass: two images—herself and the lab’s red glow. She almost reached out to touch the pane, but stopped.
VOS (softly):
“We cross thresholds once. There’s no crossing back.”
She turned off the comm channel and walked back toward the Infusion Wing, heels clicking on the metal floor.
Tonight, the Threshold Protocol moved from concept to contagion. And there was no going back.
